News

Reuters Health, August 2013

In an illustration of "herd immunity" at work, a new study shows that fewer older children and adults were hospitalized for severe diarrhea once the U.S. started vaccinating babies against rotavirus in 2006.

Read the full article

RotaFlash, August 2013

The Gambia's introduction of rotavirus vaccines stands to make a significant impact. Global Enteric Multicenter Study (GEMS), the first comprehensive global study of childhood diarrheal disease, found that rotavirus is the most common cause of moderate-to-severe diarrhea among Gambian infants and toddlers under two years of age.

Read the full article

United Nations News Centre, July 2013

The United Nations has adopted a Sanitation for All resolution and officially recognized November 19th as World Toilet Day.

Read the full press release

New York Times, July 2013

PATH's Evan Simpson and ColaLife weigh in on creating a market for ORS in the remote, rural areas where its lifesaving potential is greatest.

Read the full article.

RotaFlash, June 2013

A new study published in the British Medical Journal provides the first post-licensure data on the real-world effectiveness of Rotarix® (a rotavirus vaccine) in a GAVI-eligible country. Bolivia was the first high-mortality country to introduce Rotarix® with GAVI support, has experienced an impressive public health impact on rotavirus-related hospitalizations due to the use of rotavirus vaccines.

Read the full article

RotaFlash, June 2013

Three recent scientific studies from the U.S. Centers for Disease Control and Prevention demonstrate the powerful and real-world effectiveness of rotavirus vaccination in the US, the benefits of which extend beyond the health of infants and young children.

Read the full article

Scandinavian Biopharma, May 2013

Results from a clinical Phase I study of a novel vaccine against diarrhea caused by enterotoxigenic Escherichia coli (ETEC) found the vaccine was safe and well tolerated. ETEC is a common culprit of travelers' diarrhea, but it is also a major cause of diarrheal disease among children living in endemic countries. Future clinical studies will document the vaccine’s protective efficacy in travelers, and will study its safety and immunogenicity among children in ETEC-endemic areas.

Read the full press release.

Times of India, May 2013

A pivotal clinical study of India's first indigenous rotavirus vaccine found it to be safe and efficacious against severe rotavirus. A public-private partnership worked to develop the vaccine, which will provide an affordable addition to the global market.

Read the full article.

Washington Post, May 2013

A three-year, multi-country study designed to give researchers and public health officials a clearer picture of diarrheal disease burden found rotavirus to be the most common cause, followed by Cryptosporidium, Escherichia coli, and Shigella.

Read the full article.

RotaFlash, May 2013

A Phase III trial of a new rotavirus vaccine candidate from India demonstrates safety and efficacy. Additionally, a new study shows that rotavirus is the #1 cause of moderate-to-severe diarrhea in children less than two years old, underscoring the need for rotavirus vaccines.

Read the full article

Syndicate content